Poewe WH[au] - Search Results

Year	Number of Results
1986	4
1987	2
1988	2
1991	1
1994	1
1996	1
1998	3
1999	1
2000	1
2002	1
2003	1
2007	1
2009	2
2019	1
2020	1
2021	0

1

Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study.

Grosset DG, Dhall R, Gurevich T, Kassubek J, Poewe WH, Rascol O, Rudzinska M, Cormier J, Sedkov A, Oh C. Grosset DG, et al. Among authors: poewe wh. Parkinsonism Relat Disord. 2020 Feb;71:4-10. doi: 10.1016/j.parkreldis.2019.12.012. Epub 2019 Dec 23. Parkinsonism Relat Disord. 2020. PMID: 31927343 Free article. Clinical Trial.

2

The natural history of Parkinson's disease.

Poewe WH, Wenning GK. Poewe WH, et al. Neurology. 1996 Dec;47(6 Suppl 3):S146-52. doi: 10.1212/wnl.47.6_suppl_3.146s. Neurology. 1996. PMID: 8959983 Review.

3

A reassessment of risks and benefits of dopamine agonists in Parkinson's disease.

Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH. Antonini A, et al. Among authors: poewe wh. Lancet Neurol. 2009 Oct;8(10):929-37. doi: 10.1016/S1474-4422(09)70225-X. Epub 2009 Aug 24. Lancet Neurol. 2009. PMID: 19709931 Review.

4

The natural history of Parkinson's disease.

Poewe WH, Wenning GK. Poewe WH, et al. Ann Neurol. 1998 Sep;44(3 Suppl 1):S1-9. doi: 10.1002/ana.410440703. Ann Neurol. 1998. PMID: 9749568 Review.

5

The pharmacology of foot dystonia in parkinsonism.

Poewe WH, Lees AJ. Poewe WH, et al. Clin Neuropharmacol. 1987;10(1):47-56. doi: 10.1097/00002826-198702000-00004. Clin Neuropharmacol. 1987. PMID: 3545460 Review. No abstract available.

6

The centenary of Friederich H. Lewy 1885-1950.

Gibb WR, Poewe WH. Gibb WR, et al. Among authors: poewe wh. Neuropathol Appl Neurobiol. 1986 May-Jun;12(3):217-22. doi: 10.1111/j.1365-2990.1986.tb00135.x. Neuropathol Appl Neurobiol. 1986. PMID: 3526168 Review. No abstract available.

7

Clinical aspects of motor fluctuations in Parkinson's disease.

Poewe WH. Poewe WH. Neurology. 1994 Jul;44(7 Suppl 6):S6-9. Neurology. 1994. PMID: 8047260 Review.

8

An early report of striatonigral degeneration.

Wenning GK, Jellinger KJ, Quinn NP, Poewe WH. Wenning GK, et al. Among authors: poewe wh. Mov Disord. 2000 Jan;15(1):159-62. doi: 10.1002/1531-8257(200001)15:1<159::aid-mds1026>3.0.co;2-i. Mov Disord. 2000. PMID: 10634258 No abstract available.

9

Validation of the freezing of gait questionnaire in patients with Parkinson's disease.

Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe WH, Stocchi F, Tolosa E. Giladi N, et al. Among authors: poewe wh. Mov Disord. 2009 Apr 15;24(5):655-61. doi: 10.1002/mds.21745. Mov Disord. 2009. PMID: 19127595 Clinical Trial.

10

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group. Whone AL, et al. Among authors: poewe wh. Ann Neurol. 2003 Jul;54(1):93-101. doi: 10.1002/ana.10609. Ann Neurol. 2003. PMID: 12838524 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results